Brief: SynAct Pharma Board, Management Enter Lock-Up Agreements
23/12/2025 07:06
Dec 23 (Reuters) - SynAct Pharma AB SYNACT.ST: BOARD OF DIRECTORS AND MANAGEMENT ENTER LOCK-UP AGREEMENTS LOCK-UP AGREEMENTS FOR SHARES AND/OR OTHER SECURITIES IN COMPANY UNTIL AND INCLUDING JUNE 30, 2026. LOCK-UP PREVENTS TRANSFER OR DISPOSAL OF SHARES AND/OR OTHER SECURITIES IN COMPANY, WITH CUSTOMARY EXCEPTIONS Source text: ID:nMFNbw4khM Further company coverage: SYNACT.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development